Zum Hauptinhalt springen

Hepatitiden

11. April 2021 | Hepatitiden

Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City.

Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City. Ziff, J., Vu, T., Dvir, D. et al. Harm Reduct J 18, 38 (2021). doi.org/10.1186/s12954-021-00486-4 https://harmreductionj...

11. April 2021 | Hepatitiden

Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia.

Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia. Uusküla, A., Talu, A., Rannap, J. et al. Harm Reduct J 18, 39 (2021). doi.org/10.1186/s12954...

11. April 2021 | Hepatitiden

Homelessness, HIV, and HCV Review Collaborative Group. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Homelessness, HIV, and HCV Review Collaborative Group. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Arum C, Fraser H, Artenie AA, Biv...

11. April 2021 | Hepatitiden

The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial.

The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial. van Santen, D. K., ...

02. April 2021 | Hepatitiden

Webinar. Opioidabhängigkeit bei komorbiden Patienten aus infektiologischer Sicht. (Donnerstag 15. April 2021, Fortbildung von 18:00 – 18:45 Uhr)

Webinar. Opioidabhängigkeit bei komorbiden Patienten aus infektiologischer Sicht. (Donnerstag 15. April 2021, Fortbildung von 18:00 – 18:45 Uhr) Eine Hepatitis-Infektion erschwert die Versorgung von Suchtpatienten maßgeblich. Herr Dr. Naumann un...

02. April 2021 | Hepatitiden

Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.

Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort. Bregenzer A, Bruggmann P, Castro E, Moriggia A, Rothen M, Thurnheer MC, Vernazza P, Scheidegger C. Swiss Med Wkly. 2021 Mar 4;151:w20460. doi: 10....

02. April 2021 | Hepatitiden

SLTC Summit 2021. GEMEINSAM STARK FÜR EINE HCV-ELIMINATION 2030 (12.06.2021)

SLTC Summit 2021. GEMEINSAM STARK FÜR EINE HCV-ELIMINATION 2030 (12.06.2021) Jetzt beim SLTC Summit 2021 die Gelegenheit für Inspiration, Austausch und Vernetzung ergreifen! Der SLTC Summit findet am 12.06.2021 in Berlin statt und wird von Gilead...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten